REQUEST A DEMO
Total
USD $0.00
Search more companies

Hualan Biological Vaccine Inc. (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Hualan Biological Vaccine Inc. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hualan Biological Bacterin Inc. is mainly engaged in the research and development, production and sales of human vaccines. The company's main products include Influenza vaccine (split virion), Recombinant hepatitis b vaccine (hansenula polymorpha), Group acyw135 meningococcal polysaccharide vaccine, Influenza vaccine (split virion), inactivated, quadrivalent, Group a and c meningococcal polysaccharide vaccine, etc. The company was founded in 2005 and headquartered in Xinxiang City, Henan Province.

Headquarters
No.1, I No.1, Hualan Avenue, Xinxiang City, Henan Province
Xinxiang; Henan; Postal Code: 453003

Contact Details: Purchase the Hualan Biological Vaccine Inc. report to view the information.

Website: http://www.hualanbacterin.com

Basic Information
Total Employees:
Purchase the Hualan Biological Vaccine Inc. report to view the information.
Outstanding Shares:
Purchase the Hualan Biological Vaccine Inc. report to view the information.
Registered Capital:
Purchase the Hualan Biological Vaccine Inc. report to view the information.
Financial Auditors:
Purchase the Hualan Biological Vaccine Inc. report to view the information.
Incorporation Date:
November 09, 2005
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
67.5%
Purchase this report to view the information.
9%
Purchase this report to view the information.
5.4%
Purchase this report to view the information.
5%
Purchase this report to view the information.
1%
Subsidiaries
Xinxiang Taihang Poultry Industry Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hualan Biological Vaccine Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-76.36%
Total operating revenue
-65.02%
Operating profit (EBIT)
-58.93%
EBITDA
-8.82%
Net Profit (Loss) for the Period
-58.93%
Total assets
9.95%
Total equity
12.67%
Operating Profit Margin (ROS)
53.93%
Net Profit Margin
47.85%
Return on Equity (ROE)
-1.07%
Debt to Equity Ratio
-0.6%
Quick Ratio
0.87%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?